Last Posted: Jan 02, 2019
- Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease.
Weimbs Thomas et al. Clinical kidney journal 2018 Dec 11(Suppl 1) i27-i38 - 2019 Digital Toolkit: NATIONAL BIRTH DEFECTS PREVENTION MONTH
- Diet and Lifestyle Role in Homocysteine Metabolism in Turner's Syndrome.
Calcaterra Valeria et al. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2018 Oct - Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Salvador-Martín Sara et al. Pharmacological research 2018 Sep 136133-139 - Researchers find a way to mimic clinical trials using genetics A technique called Mendelian randomization could be the revolutionary tool drug companies have been waiting for.
G Tauber, MIT Tech Review, August 28, 2018 - Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin Erika et al. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2018 Jul 3918-40 - Personalized Nutrition-Genes, Diet, and Related Interactive Parameters as Predictors of Cancer in Multiethnic Colorectal Cancer Families.
Shiao S Pamela K et al. Nutrients 2018 Jun 10(6) - Characteristics and outcomes of patients with formiminoglutamic aciduria detected through newborn screening.
Ahrens-Nicklas Rebecca C et al. Journal of inherited metabolic disease 2018 Jun - Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.
Page Elyse C et al. Cancer letters 2018 Jun - Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.
Jenko B et al. The pharmacogenomics journal 2017 Oct 17(5) 412-418
.png)
No hay comentarios:
Publicar un comentario